Integra Lifesciences Holdings Corp

NASDAQ: IART    
Share price (5/2/24): $28.75    
Market cap (5/2/24): $2.260 billion
4 Integra Lifesciences Holdings Corp Expert Interviews, now on BamSEC.
 Powered by Tegus.

Indentures Filter

EX-4.4
from 10-K 3 pages Description of the Company’s Common Stock Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.4
from 10-K 3 pages Description of the Company’s Common Stock Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.4
from 10-K 2 pages Description of the Company’s Common Stock Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.13
from 10-K 2 pages Description of the Company’s Common Stock Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.1
from 8-K 4 pages Integra Lifesciences Holdings Corporation and Citibank, N.A., as Trustee First Supplemental Indenture Dated as of December 9, 2020
12/34/56
EX-4.13
from 10-K 2 pages Description of the Company’s Common Stock Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.2(B)
from S-3ASR 51 pages Integra Lifesciences Holdings Corporation and [ ], Trustee Indenture Dated as of , 20 Integra Lifesciences Holdings Corporation Certain Sections of This Indenture Relating to Sections 3.10 Through 3.18, Inclusive, of the Trust Indenture Act of 1939
12/34/56
EX-4.1
from 8-K 114 pages Integra Lifesciences Holdings Corporation and Citibank, N.A., as Trustee Indenture Dated as of February 7, 2020 0.50% Convertible Senior Notes Due 2025
12/34/56
EX-4.4
from S-8 29 pages Integra Lifesciences Deferred Compensation Plan Effective Date May 16, 2019
12/34/56
EX-4.1
from 8-K 171 pages Indenture or similar
12/34/56
EX-4.2
from 8-K 40 pages Ratification Agreement
12/34/56
EX-4.2
from S-3ASR 38 pages Integra Lifesciences Holdings Corporation Indenture Dated as of , 20 Trustee
12/34/56
EX-4.2
from 8-K 13 pages Ratification Agreement
12/34/56
EX-4.2
from S-3ASR 51 pages Integra Lifesciences Holdings Corporation Indenture Dated as of , 20 Trustee
12/34/56
EX-4.1
from 8-K 24 pages Second Amendment
12/34/56
EX-4.1
from 8-K ~5 pages First Amendment
12/34/56
EX-4.2
from 8-K 100 pages Integra Lifesciences Holdings Corporation and Wells Fargo Bank, National Association, as Trustee Indenture Dated as of June 15, 2011 1.625% Convertible Senior Notes Due 2016
12/34/56
EX-4.1
from 8-K 40 pages Integra Lifesciences Holdings Corporation 1.625% Convertible Senior Notes Due 2016 Purchase Agreement
12/34/56
EX-4.3
from S-3ASR 3 pages [Face of Certificate] Il [Logo] Incorporated Under the Laws of the State of Delaware Common Stock Cusip 457985 20 8 See Reverse for Certain Definitions This Certifies That Is the Owner Of
12/34/56
EX-4.3
from S-3ASR 3 pages [Face of Certificate] Il [Logo] Incorporated Under the Laws of the State of Delaware Common Stock Cusip 457985 20 8 See Reverse for Certain Definitions This Certifies That Is the Owner Of
12/34/56